Treating keratinocyte carcinomas with a combination of imiquimod, 5-fluorouracil, and tretinoin using store-and-forward telemedicine in the age of coronavirus disease 2019 to promote social distancing

William J Nahm; Evangelos V Badiavas; Robert S Kirsner; Anna J Nichols; Zechariah C Harris; Andrew R Phillips; John Shen

doi:10.1016/j.jdcr.2020.07.024

Treating keratinocyte carcinomas with a combination of imiquimod, 5-fluorouracil, and tretinoin using store-and-forward telemedicine in the age of coronavirus disease 2019 to promote social distancing

JAAD Case Rep. 2020 Sep;6(9):931-934. doi: 10.1016/j.jdcr.2020.07.024. Epub 2020 Jul 25.

Authors

William J Nahm^{1

2

3}, Evangelos V Badiavas², Robert S Kirsner^{2

4}, Anna J Nichols^{2

4}, Zechariah C Harris⁵, Andrew R Phillips⁶, John Shen³

Affiliations

¹ New York University Grossman School of Medicine, New York, New York.
² Dr Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.
³ Shen Dermatology, Temecula, California.
⁴ Sylvester Comprehensive Cancer Center, Miami, Florida.
⁵ Wake Forest School of Medicine, Winston-Salem, North Carolina.
⁶ The Ohio State University College of Medicine, Columbus, Ohio.

No abstract available

Keywords: 5-FU, 5-fluorouracil 2% solution; 5-fluorouracil; App, application; BCC, basal cell carcinoma; COVID-19; COVID-19, coronavirus disease 2019; IMI, imiquimod 5% cream; KCs, keratinocyte carcinomas; SCC, squamous cell carcinoma; TRET, tretinoin 0.1% cream; coronavirus disease 2019; imiquimod; keratinocyte carcinomas; social distancing; telemedicine; tretinoin.

Publication types

Case Reports